Data / Form D filings / GNT Pharmaceuticals, Inc.
GNT Pharmaceuticals, Inc.: Form D filing
GNT Pharmaceuticals, Inc., a pharmaceuticals company in Louisville, KY, filed a Form D with the SEC in 2025. The latest, on March 3, 2025, reports an offering of $150,000 with nothing sold yet.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 3711 QUAIL HOLLOW COURT, Louisville, KY, 40241
- Phone
- (502) 894-0295
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2024
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2057459
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Mar 3, 2025 | New notice | $150,000 | $0 | $150,000 | 0 | Yet to occur | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Phoebe Wood | Executive Officer, Director | |
| Serge Martinod | Director | |
| Dale Boden | Director | |
| Larry Horn | Executive Officer, Director | |
| Jim Corman | Director |
Every Form D from the week of Mar 3, 2025 · All recent filings in Kentucky · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what GNT Pharmaceuticals, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.